Jianmin Fang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Applied microbiology and biotechnology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Tongji University

Dalhousie University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tongji University Sep 01 2009

China

Professor :: Life Science

Education History

Dalhousie University Sep 01 1993 - Dec 01 1997

Canada

PHD :: Biology

Publications

Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal Quantification of HER2-targeting Antibody-Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (5) (2024)
Qing Wei, Teng Yang, Jiayu Zhu, Ziwen Zhang, Le Yang, Yuchao Zhang, Xiang-Dong Cheng, Jiahui Chen, Jinchao Wang, Xuefei Tian, Takaya Shimura, Jianmin Fang, Jie-Er Ying, Mengyang Fan, Peng Guo, Xiangdong Cheng
Spatiotemporal quantification of HER2-targeting antibody-drug conjugate bystander activity and enhancement of solid tumor penetration. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Xinan Sheng, Lin Wang, Zhisong He, Yanxia Shi, Hong Luo, Weiqing Han, Xin Yao, Benkang Shi, Zhenhua Liu, Changlu Hu, Ziling Liu, Hong-Qian Guo, Guohua Yu, Zhigang Ji, Jian-Ming Ying, Yun Ling, Shiying Yu, Yi Hu, Jianming Guo, Jianmin Fang, Aiping Zhou, Jun Guo
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peng Guo, Jing Huang, Bing Zhu, Andrew C Huang, Lingxiao Jiang, Jianmin Fang, Marsha A Moses
A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Science advances 9 (18) (2023)
Kaiming Chen, Dong Li, Hongwen Li, Bing Li, Jie Li, Lei Huang, Renhao Li, Xiaoqing Xu, Lingxiao Jiang, Cizhong Jiang, Hua Gu, Jianmin Fang
Genetic analysis of heterogeneous sub-clones in recombinant Chinese hamster ovary cells. Applied microbiology and biotechnology 101 (14) (2017)

Jianmin Fang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jianmin Fang